1. |
赫捷, 邵康. 中国食管癌流行病学现状、诊疗现状及未来对策. 中国癌症杂志, 2011, 21(7): 501-504.
|
2. |
Tachimori Y, Kato H. Diagnosis and surgery of esophageal cancer. Crit Rev Oncol Hematol, 1998, 28(1): 57-71.
|
3. |
Gao Q, Mok HP, Wang WP, et al. Effect of perioperative glucocorticoid administration on postoperative complications following esophagectomy: A meta-analysis. Oncol Lett, 2014, 7(2): 349-356.
|
4. |
Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicentre, open-label, randomised controlled trial. Lancet, 2012, 379(9829): 1887-1892.
|
5. |
Cruickshank AM, Fraser WD, Burns HJ, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond), 1990, 79(2): 161-165.
|
6. |
Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery, 2000, 127(2): 117-126.
|
7. |
刘又宁, 解立新. 感染相关生物标志物临床意义解读专家共识. 中华结核和呼吸杂志, 2017, 40(4): 243-257.
|
8. |
Sato N, Endo S, Kimura Y, et al. Influence of a human protease inhibitor on surgical stress induced immunosuppression. Dig Surg, 2002, 19(4): 300-305.
|
9. |
杜臻雁, 唐福林. 糖皮质激素抗炎作用机制的研究进展. 中华医学杂志, 2006, 86(35): 2512-2515.
|
10. |
史家欣, 李家树. 糖皮质激素抗炎作用机制的研究进展. 实用医学杂志, 2014, 30(6): 983-984.
|
11. |
Strehl C, Buttgereit F. Optimized glucocorticoid therapy: Teaching old drugs new tricks. Mol Cell Endocrinol, 2013, 380(1-2): 32-40.
|
12. |
杨从荣, 周咏梅, 徐涛. 甲泼尼龙的临床应用. 继续医学教育, 2006, 20(33): 61-64.
|
13. |
Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: A ten-year prospective cohort. Ann Thorac Surg, 2003, 75(1): 217-222.
|
14. |
Nakamura M, Iwahashi M, Nakamori M, et al. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg, 2008, 393(2): 127-133.
|
15. |
Stahn C, Löwenberg M, Hommes DW, et al. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol, 2007, 275(1-2): 71-78.
|
16. |
Robbins JJ. Steroid side effects, a credibility gap between fact and opinion. N Engl J Med, 1968, 279(6): 328.
|
17. |
Sauerland S, Nagelschmidt M, Mallmann P, et al. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: A systematic review. Drug Saf, 2000, 23(5): 449-461.
|
18. |
Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: Pathophysiologic effects and clinical implications. J Am Coll Surg, 2002, 195(5): 694-712.
|